Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for Ensysce Biosciences (ENSCW) over the last 5 years, with Q3 2025 value amounting to $35.0.

  • Ensysce Biosciences' Total Non-Current Liabilities fell 9891.07% to $35.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0, marking a year-over-year decrease of 9891.07%. This contributed to the annual value of $10096.0 for FY2024, which is 6174.02% down from last year.
  • Ensysce Biosciences' Total Non-Current Liabilities amounted to $35.0 in Q3 2025, which was down 9891.07% from $1033.0 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Total Non-Current Liabilities ranged from a high of $8.4 million in Q2 2022 and a low of $35.0 during Q3 2025
  • Over the past 5 years, Ensysce Biosciences' median Total Non-Current Liabilities value was $91318.0 (recorded in 2023), while the average stood at $1.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 878.23% in 2022, then tumbled by 9891.24% in 2023.
  • Ensysce Biosciences' Total Non-Current Liabilities (Quarter) stood at $8.1 million in 2021, then crashed by 94.43% to $450494.0 in 2022, then crashed by 94.14% to $26388.0 in 2023, then crashed by 61.74% to $10096.0 in 2024, then crashed by 99.65% to $35.0 in 2025.
  • Its last three reported values are $35.0 in Q3 2025, $1033.0 for Q2 2025, and $130180.0 during Q1 2025.